| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$65,496 ) |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI182549 | Molecular control of tolerogenic dendritic cell function | 000 | 2 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018520 | Partners IN CONTROL: Using Remote MonitorINg teChnology with cOmmuNity healTh woRkers to support hypertensiOn management patients at Federally QuaLified Health Centers | 000 | 4 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK127916 | BRinging the Diabetes Prevention Program to GEriatric Populations (BRIDGE) | 000 | 5 | NIH | 10/8/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K12TR005770 | CTSA K12 Program at New York University | 000 | 1 | NIH | 10/14/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA312541 | Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast Cancer | 000 | 1 | NIH | 10/14/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | H1224879 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 14 | HRSA | 10/13/2026 | $0 |
| | 2027 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21MH136644 | In vivo assessment of the mitochondrial complex I in subjects with schizophrenia | 000 | 2 | NIH | 10/9/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA282756 | Exploiting cell fate transition to overcome radiation resistance in glioblastoma | 000 | 3 | NIH | 10/8/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | KL2TR001446 | Institutional Career Development | 000 | 10 | NIH | 10/14/2026 | -$65,495 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23MH134068 | Deep Learning Based Natural Language Processing Markers of Anxiety and Depression | 000 | 3 | NIH | 10/14/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
| | 2027 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99DC021727 | Neuroplasticity and early cochlear implant use | 000 | 2 | NIH | 10/9/2026 | $0 |
| | 2027 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R03AG082995 | Feasibility of a Hearing Program in Primary Care for Underserved Older Adults | 000 | 2 | NIH | 10/15/2026 | $0 |
| | 2027 | 2024 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
| | 2027 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG062684 | Understanding the lived experience of couples across the trajectory of dementia | 000 | 5 | NIH | 10/14/2026 | -$1 |
| | 2027 | 2023 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | 90IFRE0116 | ACCESSIBLE - Advanced Communication and Care in Safety-net Systems | 01 | 2 | ACL | 10/8/2026 | $0 |
| | 2027 | 2022 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | RF1DA056394 | Dissection of spatiotemporal activity from large-scale, multi-modal, multi-resolution hippocampal-neocortical recordings. | 000 | 1 | NIH | 10/14/2026 | $0 |
|
| Issue Date FY: 2026 ( Subtotal = $462,593,264 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23NS146694 | Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children with Neurofibromatosis Type 1 | 000 | 1 | NIH | 1/23/2026 | $247,995 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI202302 | Testing the epigenetic basis and evolutionary generality of bacterial persistence | 000 | 1 | NIH | 7/1/2026 | $254,250 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR087005 | MRI as a Predictive Biomarker for Hip Arthroplasty Failure | 000 | 1 | NIH | 9/7/2026 | $661,706 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS153418 | Characterization of ARIA by neuroimaging, proteomics, and neuropathology in a Squirrel monkey model of sporadic CAA | 000 | 1 | NIH | 9/1/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL188015 | Testing various antiplatelet strategies in psoriasis to improve vascular health | 000 | 1 | NIH | 9/9/2026 | $845,590 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL181640 | Mechanisms of Sex-specific responses to obstructive sleep apnea Therapies (MoST) | 000 | 1 | NIH | 8/31/2026 | $795,421 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES038174 | Impact of Prenatal Pesticide Exposures on the Vaginal Microbiome and Pregnancy Outcomes | 000 | 1 | NIH | 9/7/2026 | $832,533 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DE035954 | Impacts of fluoride exposure on child neurodevelopment: a mechanistic study | 000 | 1 | NIH | 9/7/2026 | $691,724 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01HL188929 | Digital Sleep Intervention for Families of Young Children | 000 | 1 | NIH | 9/4/2026 | $184,873 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023485 | Neural dynamics underlying target-background separation in olfactory bulb | 001 | 1 | NIH | 9/4/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA316857 | Microplastics, Pesticides and Prostate Cancer Risk | 000 | 1 | NIH | 9/4/2026 | $387,731 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023485 | Neural dynamics underlying target-background separation in olfactory bulb | 000 | 1 | NIH | 9/4/2026 | $43,667 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | NU58DP008003 | NYU BOLD Public Health Center of Excellence on Early Detection and Management of Dementia is a national resource for CDC-funded and other entities, dedicated to improving dementia detection and care | 00 | 1 | CDC | 9/14/2026 | $986,275 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL184849 | Tissue-Specific Gene Editing via Programmable Sendai -based Vectors (PSVs) | 000 | 1 | NIH | 9/17/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL188445 | Cross-tissue multi-omic approaches to characterize the role of clonal hematopoiesis of indeterminate potential in atherosclerotic cardiovascular disease | 000 | 1 | NIH | 9/17/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31DK146642 | Examining Real-World Uptake and Effectiveness of GLP-1 RA in an Urban Population with Type-2 Diabetes | 000 | 1 | NIH | 9/17/2026 | $36,947 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM163773 | Mechanisms of gene activating and silencing chromatin complexes | 000 | 1 | NIH | 9/17/2026 | $313,896 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA312541 | Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast Cancer | 000 | 1 | NIH | 9/8/2026 | $693,638 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23AR086980 | Elucidating the role of short chain fatty acids in gut microbiome dynamics and host response in rheumatoid arthritis | 000 | 1 | NIH | 9/10/2026 | $184,896 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC024134 | Precision Glucocorticoid Therapy for Vocal Fold Disorders | 000 | 1 | NIH | 9/17/2026 | $706,136 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HD123105 | Child Health Impacts of Injury in Pregnancy (CHIIP) | 000 | 1 | NIH | 9/17/2026 | $727,664 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC023790 | Cortical mechanisms of normal and disordered human speech | 000 | 1 | NIH | 6/26/2026 | $685,327 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00EB036080 | Fast High-Resolution Microstructure Diffusion MRI Exploiting Data Redundancy | 000 | 3 | NIH | 9/1/2026 | $248,999 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23HD120657 | Drivers and Consequences of Movement Anxiety after Stroke | 000 | 1 | NIH | 8/31/2026 | $179,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34CA313437 | Development and feasibility testing of a mobile app to deliver an evidence-based intervention targeting financial stress and smoking | 000 | 1 | NIH | 6/26/2026 | $310,185 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG099916 | Post-Kidney Transplant Dementia and Alzheimer's Disease Prediction Leveraging the Pre-Transplant Evaluation Data | 000 | 1 | NIH | 9/1/2026 | $1,423,551 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99EY037847 | Investigating the mechanism of corneal lens development | 001 | 2 | NIH | 8/25/2026 | $142,749 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 003 | 4 | NIH | 9/3/2026 | $97,132 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 002 | 4 | NIH | 8/24/2026 | $186,555 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA063711 | NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS | 001 | 2 | NIH | 5/25/2026 | $775,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG103531 | Aberrant Nuclear Material Properties in Aging Cells | 000 | 1 | NIH | 8/31/2026 | $705,405 |
|
